Knowledge, attitudes and perceptions regarding lymphatic filariasis: study on systematic noncompliance with mass drug administration

被引:5
|
作者
Cabral, Silvia [1 ]
Bonfim, Cristine [2 ,3 ]
Oliveira, Rosalira [2 ]
Oliveira, Paula [4 ,5 ]
Guimaraes, Terezinha [4 ]
Brandao, Eduardo [5 ]
Aguiar-Santos, Ana Maria [5 ]
Medeiros, Zulma [5 ,6 ]
机构
[1] Fundacao Oswaldo Cruz, Ctr Pesquisa Aggeu Magalhaes, Programa Doutorado Saude Publ, Recife, PE, Brazil
[2] Fundacao Joaquim Nabuco, Dept Pesquisa Social, Recife, PE, Brazil
[3] Univ Fed Pernambuco, Programa Posgrad Integrada Saude Colet, Recife, PE, Brazil
[4] Secretaria Saude Olinda, Recife, PE, Brazil
[5] Fundacao Oswaldo Cruz, Ctr Pesquisa Aggeu Magalhaes, Dept Parasitol, Recife, PE, Brazil
[6] Univ Pernambuco, Inst Ciencias Biol, Recife, PE, Brazil
关键词
Lymphatic filariasis; Control program; Mass drug administration; Systematic noncompliance; URBAN AREAS; EPIDEMIOLOGIC SITUATION; BANCROFTIAN FILARIASIS; ENDEMIC AREA; PROGRAM; ELIMINATION; COVERAGE; BRAZIL; INDIA; DISTRICT;
D O I
10.1590/S1678-9946201759023
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of this study was to investigate the epidemiological characteristics, antigenic profile, perceptions, attitudes and practices of individuals who have been systematically noncompliant in mass drug administration (MDA) campaigns targeting lymphatic filariasis, in the municipality of Olinda, State of Pernambuco, Northeastern Brazil. A pretested questionnaire was used to obtain information on socioenvironmental demographics, perceptions of lymphatic filariasis and MDA, and reasons for systematic noncompliance with treatment. A rapid immunochromatographic test (ICT) was performed during the survey to screen for filariasis. It was found that the survey subjects knew about filariasis and MDA. Filariasis was identified as a disease (86.2%) and 74.4% associated it with the presence of swelling in the legs. About 80% knew about MDA, and the main source of information was healthcare workers (68.3%). For men the main reasons for systematic noncompliance with MDA were that "the individual had not received the medication" (p=0.03) and for women "the individual either feared experiencing adverse reactions". According to the ICT, the prevalence of lymphatic filariasis was 2%. The most important causes of systematic noncompliance were not receiving the drug and fear of side-effects. For successful implementation of MDA programs, good planning, educational campaigns promoting the benefits of MDA, adoption of measures to minimize the impact of adverse effects and improvement of drug distribution logistics are needed.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Evaluation of mass drug administration in the program to control imported lymphatic filariasis in Thailand
    Tanaporn Toothong
    Mathuros Tipayamongkholgul
    Nawarat Suwannapong
    Saravudh Suvannadabba
    BMC Public Health, 15
  • [32] INCREASING ADHERENCE TO MASS DRUG ADMINISTRATION FOR LYMPHATIC FILARIASIS - ORISSA STATE, INDIA
    Cantey, Paul T.
    Rout, Jonathan
    Rao, Grace
    Dhir, Soumendra
    Fox, LeAnne
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 79 (06): : 327 - 327
  • [33] Factors influencing compliance to mass drug administration for control of lymphatic filariasis in Tanzania
    Meyrowitsch, D.
    Kisoka, W.
    Mushi, D.
    Malecela, M.
    Simonsen, P.
    Tersboel, B.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2013, 18 : 55 - 55
  • [34] Assessing knowledge about lymphatic filariasis and the implementation of mass drug administration amongst drug deliverers in three districts/cities of Indonesia
    Titaley, Christiana R.
    Damayanti, Rita
    Soeharno, Nugroho
    Mu'asyaroh, Anifatun
    Bradley, Mark
    Lynam, Tim
    Krentel, Alison
    PARASITES & VECTORS, 2018, 11
  • [35] A systematic review of factors that shape implementation of mass drug administration for lymphatic filariasis in sub-Saharan Africa
    Silumbwe, Adam
    Zulu, Joseph Mumba
    Halwindi, Hikabasa
    Jacobs, Choolwe
    Zgambo, Jessy
    Dambe, Rosalia
    Chola, Mumbi
    Chongwe, Gershom
    Michelo, Charles
    BMC PUBLIC HEALTH, 2017, 17
  • [36] Symptoms reported after mass drug administration for lymphatic filariasis in Leogane, Haiti
    Hochberg, Natasha
    Michel, Marie C.
    Lammie, Patrick J.
    Mathieu, Els
    Direny, Abdel N.
    De Rochars, Madsen Beau
    Addiss, David G.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (05): : 928 - 932
  • [37] Cessation of Mass Drug Administration for Lymphatic Filariasis in Zanzibar in 2006: Was Transmission Interrupted?
    Rebollo, Maria P.
    Mohammed, Khalfan A.
    Thomas, Brent
    Ame, Shaali
    Ali, Said Mohammed
    Cano, Jorge
    Gonzalez Escalada, Alba
    Bockarie, Moses J.
    PLOS NEGLECTED TROPICAL DISEASES, 2015, 9 (03):
  • [38] Genetic epidemiology of lymphatic filariasis in American Samoa after mass drug administration
    Hedtke, Shannon M.
    Zendejas-Heredia, Patsy A.
    Graves, Patricia M.
    Sheridan, Sarah
    Sheel, Meru
    Fuimaono, Saipale D.
    Lau, Colleen L.
    Grant, Warwick N.
    INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2021, 51 (2-3) : 137 - 147
  • [39] Evaluation of mass drug administration in the program to control imported lymphatic filariasis in Thailand
    Toothong, Tanaporn
    Tipayamongkholgul, Mathuros
    Suwannapong, Nawarat
    Suvannadabba, Saravudh
    BMC PUBLIC HEALTH, 2015, 15
  • [40] EVALUATION OF MASS DRUG ADMINISTRATION CAMPAIGN AGAINST LYMPHATIC FILARIASIS AT BIDAR DISTRICT
    Hussain, Mubeen
    Kumar, Sunil D.
    Nigudgi, S. R.
    Reddy, Shrinivas
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2013, 2 (20): : 3561 - 3567